Semin Immunol. 1990 Sep;2(5):369-74.

Adjuvant formulations and their mode of action.

Source

Syntech Research, Palo Alto, CA 94304.

Abstract

We have developed an adjuvant formulation (SAF) consisting of a synthetic muramyl dipeptide analogue (N-acetylmuramyl-L-threonyl-D-isoglutamine) in a squalane-Pluronic polymer emulsion. Used with a variety of antigens SAF elicits cell-mediated immunity and antibodies of protective isotypes (IgG2a in the mouse). SAF augments responses to influenza virus haemagglutinin and hepatitis B virus surface antigen. Vaccines using SAF have protected guinea pigs against genital herpes simplex virus infections and subhuman primates against Epstein-Barr virus and simian immunodeficiency virus infections. Properties of SAF are compared with those of other adjuvants, including lipopolysaccharide analogs, ISCOMs and liposomes.

PMID:: 1966859; [PubMed - indexed for MEDLINE]

LinkOut - more resources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Medical

Immunization - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

Immunological adjuvants: desirable properties and side-effects. [Mol Immunol. 1991]
Immunological adjuvants: desirable properties and side-effects.
Allison AC, Byars NE. Mol Immunol. 1991 Mar; 28(3):279-84.
Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity. [Vaccine. 1987]
Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity.
Byars NE, Allison AC. Vaccine. 1987 Sep; 5(3):223-8.
Improvement of hepatitis B vaccine by the use of a new adjuvant. [Vaccine. 1991]
Improvement of hepatitis B vaccine by the use of a new adjuvant.
Byars NE, Nakano G, Welch M, Lehman D, Allison AC. Vaccine. 1991 May; 9(5):309-18.
Review An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity. [J Immunol Methods. 1986]
Review An adjuvant formulation that selectively elicits the formation of antibodies of protective isotypes and of cell-mediated immunity.
Allison AC, Byars NE. J Immunol Methods. 1986 Dec 24; 95(2):157-68.
Review Immunological adjuvants and their modes of action. [Arch Immunol Ther Exp (Warsz)....]
Review Immunological adjuvants and their modes of action.
Allison AC. Arch Immunol Ther Exp (Warsz). 1997; 45(2-3):141-7.

See reviews... See all...

Cited by 4 PubMed Central articles

Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine design. [Vaccine. 2009]
Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine design.
Morgan EL, Morgan BN, Stein EA, Vitrs EL, Thoman ML, Sanderson SD, Phillips JA. Vaccine. 2009 Dec 11; 28(2):463-9. Epub 2009 Oct 15.
The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells. [Biomaterials. 2009]
The effect of the nonionic block copolymer pluronic P85 on gene expression in mouse muscle and antigen-presenting cells.
Gaymalov ZZ, Yang Z, Pisarev VM, Alakhov VY, Kabanov AV. Biomaterials. 2009 Feb; 30(6):1232-45. Epub 2008 Dec 7.
Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates. [Infect Immun. 1994]
Immunization against Porphyromonas gingivalis inhibits progression of experimental periodontitis in nonhuman primates.
Persson GR, Engel D, Whitney C, Darveau R, Weinberg A, Brunsvold M, Page RC. Infect Immun. 1994 Mar; 62(3):1026-31.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Adjuvant formulations and their mode of action.
Adjuvant formulations and their mode of action.
Semin Immunol. 1990 Sep ;2(5):369-74.

PubMed
The role of inflammation and antiinflammation therapies in keratoconjunctivitis ...
The role of inflammation and antiinflammation therapies in keratoconjunctivitis sicca.
Clin Ophthalmol. 2009 ;3:57-67. Epub 2009 Jun 2 .

PubMed
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular herpes.
Clin Ophthalmol. 2007 Dec ;1(4):441-53.

PubMed
Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatme...
Levobetaxolol hydrochloride: a review of its pharmacology and use in the treatment of chronic open-angle glaucoma and ocular hypertension.
Clin Ophthalmol. 2007 Jun ;1(2):93-7.

PubMed
Collagen cross-linking: Strengthening the unstable cornea.
Collagen cross-linking: Strengthening the unstable cornea.
Clin Ophthalmol. 2008 Dec ;2(4):863-7.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Adjuvant formulations and their mode of action.

Source

Abstract

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Other Literature Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Cited by 4 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information